Your browser doesn't support javascript.
loading
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study.
Roberto, Michela; Arrivi, Giulia; Pilozzi, Emanuela; Montori, Andrea; Balducci, Genoveffa; Mercantini, Paolo; Laghi, Andrea; Ierinò, Debora; Panebianco, Martina; Marinelli, Daniele; Tomao, Silverio; Marchetti, Paolo; Mazzuca, Federica.
Afiliación
  • Roberto M; Department of Radiological, Oncological and Anatomo-Pathological Sciences, Medical Oncology Unit A, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Arrivi G; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Oncology Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Pilozzi E; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Anatomia Patologica Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Montori A; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Anatomia Patologica Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Balducci G; Department of Medical-Surgical Sciences and Translation Medicine, Sapienza University of Rome, Gastro-intestinal Surgery Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Mercantini P; Department of Medical-Surgical Sciences and Translation Medicine, Sapienza University of Rome, Gastro-intestinal Surgery Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Laghi A; Department of Medical-Surgical Sciences and Translation Medicine, Sapienza University of Rome, Radiology Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Ierinò D; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Oncology Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Panebianco M; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Oncology Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Marinelli D; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Tomao S; Department of Radiological, Oncological and Anatomo-Pathological Sciences, Medical Oncology Unit A, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Marchetti P; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Oncology Unit, Sant' Andrea University Hospital, Rome, Italy.
  • Mazzuca F; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Oncology Unit, Sant' Andrea University Hospital, Rome, Italy.
Cancer Manag Res ; 14: 1353-1369, 2022.
Article en En | MEDLINE | ID: mdl-35418781

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2022 Tipo del documento: Article País de afiliación: Italia